Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yanzhao Xu, Na Wang, Rongfeng Liu, Huilai Lv, Zhenhua Li, Fan Zhang, Chunyue Gai & Ziqiang Tian. (2021) Epigenetic Study of Esophageal Carcinoma Based on Methylation, Gene Integration and Weighted Correlation Network Analysis. OncoTargets and Therapy 14, pages 3133-3149.
Read now
Read now
Maura Torres-Aguilera & José María Remes Troche. (2018) Achalasia and esophageal cancer: risks and links. Clinical and Experimental Gastroenterology 11, pages 309-316.
Read now
Read now
Articles from other publishers (17)
Liangliang Wu, Yiming Gao, Shengzhi Xie, Wan Ye, Yasushi Uemura, Rong Zhang, Yanju Yu, Jinfeng Li, Man Chen, Qiyan Wu, Pengfei Cui, Hongyu Liu, Shuai Mu, Yilan Li, Lingxiong Wang, Chunxi Liu, Jiahui Li, Lijun Zhang, Shunchang Jiao, Guoqing Zhang & Tianyi Liu. (2023) The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma. Translational Oncology 37, pages 101775.
Crossref
Crossref
Yan Xie, Ruimin Fu, Zheng Xiao & Gang Li. (2022) A Risk Model Based on Immune-Related Genes Predicts Prognosis and Characterizes the Immune Landscape in Esophageal Cancer. Pathology and Oncology Research 28.
Crossref
Crossref
Ying Zhu, Wang Yao, Bing-Chen Xu, Yi-Yan Lei, Qi-Kun Guo, Li-Zhi Liu, Hao-Jiang Li, Min Xu, Jing Yan, Dan-Dan Chang, Shi-Ting Feng & Zhi-Hua Zhu. (2021) Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers. BMC Cancer 21:1.
Crossref
Crossref
Kai Qin, Yi Cheng, Jing Zhang, Xianglin Yuan, Jianhua Wang & Jian Bai. (2020) Prognostic risk model construction and prognostic biomarkers identification in esophageal adenocarcinoma based on immune-related long noncoding RNA*. Oncology and Translational Medicine 6:3, pages 109-115.
Crossref
Crossref
Dimitrios Schizas, Nikolaos Charalampakis, Christo Kole, Konstantinos S Mylonas, Ioannis Katsaros, Meina Zhao, Jaffer A Ajani, Amanda Psyrri, Michalis V Karamouzis & Theodore Liakakos. (2020) Immunotherapy for esophageal cancer: a 2019 update. Immunotherapy 12:3, pages 203-218.
Crossref
Crossref
Ting‐Yao Wang, Vincent Chin‐Hung Chen, Yao‐Hsu Yang, Chao‐Yu Chen, Chuan‐Pin Lee & Shu‐I Wu. (2018) The effects of anxiety on the receipt of treatments for esophageal cancer. Psycho-Oncology 28:1, pages 31-38.
Crossref
Crossref
Giovanni G Giobbe, Alessandro Zambon, Massimo Vetralla, Luca Urbani, Koichi Deguchi, Maria F Pantano, Nicola M Pugno, Nicola Elvassore, Paolo De Coppi & Sara Spilimbergo. (2018) Preservation over time of dried acellular esophageal matrix. Biomedical Physics & Engineering Express 4:6, pages 065021.
Crossref
Crossref
Feng He, Bo Ai & Lei Tian. (2018) Identification of genes and pathways in esophageal adenocarcinoma using bioinformatics analysis. Biomedical Reports.
Crossref
Crossref
Cui‑Juan Qian, Yong‑Xiao Qi, Xiao‑Ying Chen, Ju‑Ping Zeng & Jun Yao. (2017) Sporamin suppresses growth of human esophageal squamous cell carcinoma cells by inhibition of NF‑κB via an AKT‑independent pathway. Molecular Medicine Reports.
Crossref
Crossref
Quan Chen, Guanghua Luo & Xiaoying Zhang. (2017) MiR‑148a modulates HLA‑G expression and influences tumor apoptosis in esophageal squamous cell carcinoma. Experimental and Therapeutic Medicine.
Crossref
Crossref
U. Ronellenfitsch, M. Schwarzbach, R. Hofheinz, P. Kienle, K. Nowak, M. Kieser, T.E. Slanger, B. Burmeister, D. Kelsen, D. Niedzwiecki, C. Schuhmacher, S. Urba, C. van de Velde, T.N. Walsh, M. Ychou & K. Jensen. (2017) Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs). European Journal of Surgical Oncology (EJSO) 43:8, pages 1550-1558.
Crossref
Crossref
Bhawna Gupta & Narinder Kumar. (2017) Worldwide incidence, mortality and time trends for cancer of the oesophagus. European Journal of Cancer Prevention 26:2, pages 107-118.
Crossref
Crossref
Ting Xi & Guizhi Zhang. (2017) Epigenetic regulation on the gene expression signature in esophagus adenocarcinoma. Pathology - Research and Practice 213:2, pages 83-88.
Crossref
Crossref
Fergus Noble, Toby Mellows, Leo H. McCormick Matthews, Adrian C. Bateman, Scott Harris, Timothy J. Underwood, James P. Byrne, Ian S. Bailey, Donna M. Sharland, Jamie J. Kelly, John N. Primrose, Surinder S. Sahota, Andrew R. Bateman, Gareth J. Thomas & Christian H. Ottensmeier. (2016) Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma. Cancer Immunology, Immunotherapy 65:6, pages 651-662.
Crossref
Crossref
Renata Hezova, Alena Kovarikova, Josef Srovnal, Milada Zemanova, Tomas Harustiak, Jiri Ehrmann, Marian Hajduch, Marek Svoboda, Milana Sachlova & Ondrej Slaby. (2015) Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus. Diagnostic Pathology 10:1.
Crossref
Crossref
Elisabete Fernandes, Andreia Peixoto, Manuel Neves, Luís Pedro Afonso, Lúcio Lara Santos & José Alexandre Ferreira. (2015)
Humoral response against sialyl-Le
a
glycosylated protein species in esophageal cancer: Insights for immunoproteomic studies
. ELECTROPHORESIS 36:23, pages 2902-2907.
Crossref
Crossref
Li-Yu Hu, Fan-Chen Ku, Yen-Po Wang, Cheng-Che Shen, Yu-Wen Hu, Chiu-Mei Yeh, Pan-Ming Chen, Huey-Ling Chiang, Ti Lu, Tzeng-Ji Chen, Chung-Jen Teng & Chia-Jen Liu. (2014) Anxiety and depressive disorders among patients with esophageal cancer in Taiwan: a nationwide population-based study. Supportive Care in Cancer 23:3, pages 733-740.
Crossref
Crossref